Diabetic nephropathy (DN) is the principal cause of mortality and morbidity in diabetic patients, the progression of which correlates best with tubulointerstitial fibrosis (TIF). Advanced oxidation protein products (AOPPs) have been detected in patients with chronic renal failure, causing injuries to proximal tubular epithelial cells. CD36, a known receptor for AOPP, is an important modulator of lipid homeostasis, predisposing to renal tubular damage. However, whether AOPPs induce lipotoxicity via the CD36 receptor pathway remains unknown. Herein, we tested the hypothesis that AOPPs accumulation in diabetes incurs lipotoxicity, causing renal TIF via the CD36 signaling pathway.
Results:
In DN patients and diabetic mice in vivo, AOPPs overload induces lipogenesis (upregulation of CD36 and sterol regulatory element-binding protein 1), fibrosis (upregulation of Fibronectin), and renal function decline (increased serum creatinine and N-acetyl-β-d-glucosaminidase, decreased estimated glomerular filtration rate). In HK-2 cells in vitro, high glucose stimulated AOPPs-induced lipotoxicity, apoptosis, and fibrosis via the CD36 receptor pathway. In addition, apocynin abrogated AOPPs-induced lipid accumulation and CD36 inhibition significantly mitigated AOPPs-induced mitochondrial injuries, lipotoxicity, and renal fibrosis. Further, we provide mechanistic evidence that AOPPs overload induces the enrichment of β-catenin binding the CD36 promoter region.
Innovation and Conclusion:
Our data reveal a major role of AOPPs in triggering lipotoxicity and fibrosis via CD36-dependent Wnt/β-catenin activation, providing new evidence for understanding the role of lipid accumulation in DN.
Get full access to this article
View all access options for this article.
References
1.
AckersI, SzymanskiC, DuckettKJ, ConsittLA, SilverMJ, and MalgorR. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. Cardiovasc Pathol, 34: 1–8, 2018.
2.
AlmeidaPE, RoqueNR, MagalhaesKG, MattosKA, TeixeiraL, Maya-MonteiroC, AlmeidaCJ, Castro-Faria-NetoHC, RyffelB, QuesniauxVF, and BozzaPT. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection. Biochim Biophys Acta, 1841: 97–107, 2014.
3.
AnusornvongchaiT, NangakuM, JaoTM, WuCH, IshimotoY, MaekawaH, TanakaT, ShimizuA, YamamotoM, SuzukiN, SassaR, and InagiR. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response. Kidney Int, 94: 536–550, 2018.
4.
BaiX, HouX, TianJ, GengJ, and LiX. CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARgamma pathway. Oncotarget, 7: 36510–36528, 2016.
5.
BaiX, LiX, TianJ, XuL, WanJ, and LiuY. A new model of diabetic nephropathy in C57BL/6 mice challenged with advanced oxidation protein products. Free Radic Biol Med, 118: 71–84, 2018.
6.
BornfeldtKE, KramerF, BatorskyA, ChoiJ, HudkinsKL, TontonozP, AlpersCE, and KanterJE. A novel type 2 diabetes mouse model of combined diabetic kidney disease and atherosclerosis. Am J Pathol, 188: 343–352, 2018.
7.
CefaluWT, BuseJB, TuomilehtoJ, FlemingGA, FerranniniE, GersteinHC, BennettPH, RamachandranA, RazI, RosenstockJ, and KahnSE. Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from a diabetes care editors' expert forum. Diabetes Care, 39: 1186–1201, 2016.
8.
ChungKW, LeeEK, LeeMK, OhGT, YuBP, and ChungHY. Impairment of PPARalpha and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol, 29: 1223–1237, 2018.
9.
ClementeC, RiusC, Alonso-HerranzL, Martin-AlonsoM, PollanA, CamafeitaE, MartinezF, MotaRA, NunezV, RodriguezC, SeikiM, Martinez-GonzalezJ, AndresV, RicoteM, and ArroyoAG. MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis. Nat Commun, 9: 910, 2018.
HindenL, UdiS, DroriA, GammalA, NemirovskiA, HadarR, BaraghithyS, PermyakovaA, GeronM, CohenM, Tsytkin-KirschenzweigS, RiahiY, LeibowitzG, NahmiasY, PrielA, and TamJ. Modulation of renal GLUT2 by the cannabinoid-1 receptor: implications for the treatment of diabetic nephropathy. J Am Soc Nephrol, 29: 434–448, 2018.
14.
KangHM, AhnSH, ChoiP, KoYA, HanSH, ChingaF, ParkAS, TaoJ, SharmaK, PullmanJ, BottingerEP, GoldbergIJ, and SusztakK. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med, 21: 37–46, 2015.
15.
KhanS, Abu JawdehBG, GoelM, SchillingWP, ParkerMD, PuchowiczMA, YadavSP, HarrisRC, El-MeanawyA, HoshiM, ShinlapawittayatornK, DeschenesI, FickerE, and SchellingJR. Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. J Clin Invest, 124: 1057–1068, 2014.
16.
KimT, NasonS, HollemanC, PepinM, WilsonL, BerryhillTF, WendeAR, SteeleC, YoungME, BarnesS, DruckerDJ, FinanB, DiMarchiR, Perez-TilveD, TschoepM, and HabeggerKM. Glucagon-receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21. Diabetes, 67: 1773–1782, 2018.
17.
Le MasterE, HuangRT, ZhangC, BogachkovY, ColesC, ShentuTP, ShengY, FancherIS, NgC, ChristoforidisT, SubbaiahPV, BerdyshevE, QainZ, EddingtonDT, LeeJ, ChoM, FangY, MinshallRD, and LevitanI. Proatherogenic flow increases endothelial stiffness via enhanced CD36-mediated uptake of oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol, 38: 64–75, 2018.
18.
LeeM, KaterelosM, GleichK, GalicS, KempBE, MountPF, and PowerDA. Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin. J Am Soc Nephrol, 29: 2326–2336, 2018.
19.
LiX, XuL, HouX, GengJ, TianJ, LiuX, and BaiX. Advanced oxidation protein products aggravate tubulointerstitial fibrosis through protein kinase C-dependent mitochondrial injury in early diabetic nephropathy. Antioxid Redox Signal, 30: 1162–1185, 2019.
20.
McDougalAD and DeweyCF Jr. Modeling oxygen requirements in ischemic cardiomyocytes. J Biol Chem, 292: 11760–11776, 2017.
21.
MinamiS, YamamotoT, TakabatakeY, TakahashiA, NambaT, MatsudaJ, KimuraT, KaimoriJY, MatsuiI, HamanoT, TakedaH, TakahashiM, IzumiY, BambaT, MatsusakaT, NiimuraF, and IsakaY. Lipophagy maintains energy homeostasis in the kidney proximal tubule during prolonged starvation. Autophagy, 13: 1629–1647, 2017.
22.
OkunoY, FukuharaA, HashimotoE, KobayashiH, KobayashiS, OtsukiM, and ShimomuraI. oxidative stress inhibits healthy adipose expansion through suppression of SREBF1-mediated lipogenic pathway. Diabetes, 67: 1113–1127, 2018.
PolichnowskiAJ, LanR, GengH, GriffinKA, VenkatachalamMA, and BidaniAK. Severe renal mass reduction impairs recovery and promotes fibrosis after AKI. J Am Soc Nephrol, 25: 1496–1507, 2014.
25.
Rodriguez-RomoR, BenitezK, Barrera-ChimalJ, Perez-VillalvaR, GomezA, Aguilar-LeonD, Rangel-SantiagoJF, HuertaS, GambaG, UribeN, and BobadillaNA. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease. Kidney Int, 89: 363–373, 2016.
26.
SabounyR, FraunbergerE, GeoffrionM, NgA, BairdS, ScreatonR, MilneR, McBrideHM, and ShuttT. The Keap1-Nrf2 stress response pathway promotes mitochondrial hyperfusion through degradation of the mitochondrial fission protein Drp1. Antioxid Redox Signal, 27: 1447–1459, 2017.
ZhouL, YuM, ArshadM, WangW, LuY, GongJ, GuY, LiP, and XuL. Coordination among lipid droplets, peroxisomes and mitochondria regulates energy expenditure through the CIDE-ATGL-PPARalpha pathway in adipocytes. Diabetes, 67: 1935–1948, 2018.
36.
ZhouZ, WanJ, HouX, GengJ, LiX, and BaiX. MicroRNA-27a promotes podocyte injury via PPARgamma-mediated beta-catenin activation in diabetic nephropathy. Cell Death Dis, 8: e2658, 2017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
